PR Newswire·Nov 11, 2026, 4:30 PM ET

Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook

CTVA

Corteva reported third-quarter 2026 net sales of $1.59 billion, a 9% decrease year-over-year, with organic sales also down 9% due to pricing pressure in North America and Latin America.
Full-year 2026 YTD net sales declined 1% to $5.36 billion, while organic sales fell 4% as price drops of 4% offset volume growth in most regions.
The company updated its full-year 2026 guidance to reflect weaker market conditions in Brazil, now expecting Adjusted Pro Forma Operating EBITDA between $1.1 billion and $1.125 billion.
Adjusted Pro Forma Operating EPS for 2026 is expected to range from $0.76 to $0.80 per share, down from previous projections due to Brazil's soft market.
Third-quarter GAAP loss from continuing operations was $54 million, compared to a $60 million profit in the prior year, while Adjusted Pro Forma Operating EBITDA dropped 17% to $222 million.
Latin America organic sales plunged 31% driven by a 24% volume decline caused by farmer liquidity constraints, high interest rates, and elevated channel inventory.
North America achieved 7% organic sales growth with a 19% volume increase, though U.S. acetochlor pricing faced headwinds.
EMEA reported 14% organic sales growth driven by strong demand for new products, while price remained flat.
Asia Pacific delivered 5% organic sales growth with 7% volume expansion, supported by new product demand despite a 2% price decline.
CEO Luke Kissam noted that while innovation and productivity performed well outside Latin America, pricing pressure on mature molecules and acetochlor significantly impacted results.
The Board of Directors authorized the first common dividend post-spin, and the company expects to record $130 million to $140 million in net pre-tax restructuring charges during 2026.

Company: Corteva, Inc.
Keywords: Corteva, Inc.